Differential expression and phosphorylation of particular Fos family members by kainate in nuclear and cytosolic fractions of murine hippocampus

Neuroscience

Volumn 100, Issue 3, 2000, Pages 453-463

  Manabe, T ^a   Kitayama, T ^b   Ogita, K ^a   Yoneda, Y ^b  

^a SETSUNAN UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

Activator protein 1; Fos family; Kainate; Phosphorylation; Serine; Tyrosine

Indexed keywords

KAINIC ACID; PROTEIN C FOS; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CYTOSOL; DNA BINDING; HIPPOCAMPUS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PYRAMIDAL NERVE CELL;

ANIMAL; CELL NUCLEUS; CYTOSOL; DNA-BINDING PROTEINS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; KAINIC ACID; MALE; MICE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-FOS; SUPPORT, NON-U.S. GOV'T; TISSUE DISTRIBUTION; TRANSCRIPTION FACTORS;

EID: 0034721539     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00284-0     Document Type: Article

References (40)

1. Abate C., Marshak D.R., Curran T. Fos is phosphorylated by p34cdc2, cAMP-dependent protein kinase and protein kinase C at multiple sites clustered within regulatory regions. Oncogene. 6:1991;2179-2185.
2. Anient F., Papavassiliou A.G., Knecht E., Roche E. Selective uptake and degradation of c-Fos and v-Fos by rat liver lysosomes. Fedn Eur. biochem. Socs Lett. 390:1996;47-52.
3. Azuma Y., Ogita K., Yoneda Y. Particular nuclear transcription factors responsive to systemic administration of kainic acid in murine brain. Neurochem. Int. 29:1996;289-299.
4. Barber J.R., Verma I.M. Modification of fos proteins: phosphorylation of c-fos, but not v-fos, is stimulated by 12-tetradecanoyl-phorbol-13-acetate and serum. Molec. cell. Biol. 7:1987;2201-2211.
5. Bing G., McMillan M., Kim H., Pennypacker K., Feng Z., Qi Q., Kong L.-Y., Iadarola M., Hong J.S. Long-term expression of the 35,000 mol. wt Fos-related antigen in rat brain after kainic acid treatment. Neuroscience. 73:1996;1159-1174.
6. Cameron H.A., Woolley C.S., McEwen B., Gould E. Differentiation of newly born neurons and glia in the dentate gyrus of the adult rat. Neuroscience. 56:1993;337-344.
7. Cameron H.A., McEwen B.S., Gould E. Regulation of adult neurogenesis by excitatory input and NMDA receptor activation in the dentate gyrus. J. Neurosci. 15:1995;4687-4692.
8. Chen R.-H., Abate C., Blenis J. Phosphorylation of the c-Fos transrepression domain by mitogen-activated protein kinase and 90-kDa ribosomal S6 kinase. Proc. natn. Acad. Sci. USA. 90:1993;10,952-10,956.
9. Ciechanover A., DiGiuseppe J.A., Bercovich B., Orian A., Richter J.D., Schwartz A.L., Brodeur G.M. Degradation of nuclear oncoproteins by the ubiquitin system in vitro. Proc. natn. Acad. Sci. USA. 88:1991;139-143.
10. Cole A.J., Saffen D.W., Baraban J.M., Worley P.F. Rapid increase of an immediate early gene messenger RNA in hippocampal neurons by synaptic NMDA receptor activation. Nature. 340:1989;474-476.
11. Curran T., Franza B.R. Jr. Fos and Jun: the AP1 connection. Cell. 55:1988;395-397.
12. Daval J.L., Nakajima T., Gleiter C.H., Post R.M., Marangos P.J. Mouse brain c-fos mRNA distribution following a single electroconvulsive shock. J. Neurochem. 52:1989;1954-1957.
13. Deng T., Karin M. c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK. Nature. 371:1994;171-175.
14. Dragunow M., Robertson H.A. Generalized seizures induce c-fos protein(s) in mammalian neurons. Neurosci. Lett. 82:1987;157-161.
15. Dragunow M., Robertson H.A. Kindling stimulation induces c-fos protein(s) in granule cells of the rat dentate gyrus. Nature. 329:1987;441-442.
16. Egebjerg J., Bettler B., Hermans-Borgmeyer I., Heinemann S. Cloning of a cDNA for a glutamate receptor subunit activated by kainate but not AMPA. Nature. 351:1991;745-748.
17. Gall C., Sumikawa K., Lynch G. Levels of mRNA for a putative kainate receptor are affected by seizures. Proc. natn. Acad. Sci. USA. 87:1990;7643-7647.
18. Good P.F., Huntley G.W., Rogers S.W., Heinemann S.F., Morrison J.H. Organization and quantitative analysis of kainate receptor subunit GluR5-7 immunoreactivity in monkey hippocampus. Brain Res. 624:1993;347-353.
19. Hermida-Matsumoto M.L., Chock P.B., Curran T., Yang D.C. Ubiquitinylation of transcription factors c-Jun and c-Fos using reconstituted ubiquitinylating enzymes. J. biol. Chem. 271:1996;4930-4936.
20. Kaminska B., Filipkowski R.K., Zurkowska G., Lason W., Przewlocki G., Kaczmarek L. Dynamic changes in the composition of the AP-1 transcription factor DNA-binding activity in rat brain following kainate-induced seizures and cell death. Eur. J. Neurosci. 6:1994;1558-1566.
21. Karin M. Signal transduction from cell surface to nucleus in development and disease. Fedn Proc. Fedn Am. Socs exp. Biol. 6:1992;2581-2590.
22. Kitayama T., Ogita K., Yoneda Y. Sustained potentiation of AP1 DNA binding is not always associated with neuronal death following systemic administration of kainic acid in murine hippocampus. Neurochem. Int. 35:1999;453-462.
23. Le Gal La Salle G. Long-lasting and sequential increase of c-fos oncoprotein expression in kainic acid-induced status epilepticus. Neurosci. Lett. 88:1988;127-130.
24. Mandelzys A., Gruda M.A., Bravo R., Morgan J.I. Absence of a persistently elevated 37 kDa Fos-related antigen and AP-1-like DNA-binding activity in the brains of kainic acid-treated fosB null mice. J. Neurosci. 15:1997;5407-5415.
25. Ofir R., Dwarki V.J., Rasshid D., Verma I.M. Phosphorylation of the C-terminus of Fos protein is required for transcriptional transrepression of the c-fos promoter. Nature. 348:1990;80-82.
26. Ogita K., Yoneda Y. Selective potentiation of DNA binding activities of both activator protein-1 and cyclic AMP response element binding protein through in vivo activation of N-methyl-D-aspartate receptor complex in mouse brain. J. Neurochem. 63:1994;525-534.
27. Pennypacker K.R., Thai L., Hong J.-S., McMillan M.K. Prolonged expression of AP-1 transcription factors in the rat hippocampus after systemic kainate treatment. J. Neurosci. 14:1994;3998-4006.
28. Pennypacker K.R., Hong J.-S., McMillan M.K. Pharmacological regulation of AP-1 transcription factor DNA binding activity. Fedn Proc. Fedn Am. Socs exp. Biol. 8:1994;475-478.
29. Popovici T., Represa A., Crepel V., Barbin G., Beadoin M., Ben-Ari Y. Effects of kainic acid-induced seizures and ischemia on c-fos-like proteins in rat brain. Brain Res. 536:1990;183-194.
30. Represa A., Tremblay E., Ben-Ari Y. Kainate binding sites in the hippocampal mossy fibers: localization and plasticity. Neuroscience. 20:1987;739-748.
31. Sakurai-Yamashita Y., Sassone-Corsi P., Gombos G. Immunohistochemistry of c-fos in mouse brain during postnatal development: basal levels and changing response to metrazol and kainate. Eur. J. Neurosci. 3:1991;764-770.
32. Sassone-Corsi P., Sisson J.C., Verma I.M. Transcriptional autoregulation of the proto-oncogene fos. Nature. 334:1988;314-319.
33. Schreiber E., Matthias P., Müller M.M., Schaffner W. Rapid detection of octamer binding proteins with "mini-extract", prepared from a small number of cells. Nucleic Acids Res. 17:1989;6419.
34. Sonnenberg J.L., Mitchelmore C., Macgregor-Leon P.F., Hempstead J., Morgan J.I., Curran T. Glutamate receptor agonists increase the expression of Fos, Fra, and AP-1 DNA binding activity in the mammalian brain. J. Neurosci. Res. 24:1989;72-80.
35. Stancovski I., Gonen H., Orian A., Schwartz A.L., Ciechanover A. Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: identification and characterization of the conjugated enzymes. Molec. cell. Biol. 15:1995;7106-7116.
36. Tratner I., Ofir R., Verma I.M. Alteration of a cyclic AMP-dependent protein kinase phosphorylation site in the c-Fos protein augments its transforming potential. Molec. cell. Biol. 12:1992;998-1006.
37. 3H]glutamate receptor binding assays. Analyt. Biochem. 177:1989;250-255.
38. Yoneda Y., Ogita K. Rapid and selective enhancement of DNA binding activity of the transcription factor AP1 by systemic administration of N-methyl-D-aspartate in murine hippocampus. Neurochem. Int. 25:1994;263-271.
39. Yoneda Y., Ogita K., Azuma Y., Ikeda M., Tagami H., Manabe T. N-Methyl-D-aspartate signaling to nuclear activator protein-1 through mechanisms different from those for kainate signaling in murine brain. Neuroscience. 90:1999;519-533.
40. Yoneda Y., Ogita K., Azuma Y., Kuramoto N., Manabe T., Kitayama T. Predominant expression of nuclear activator protein-1 complex with DNA binding activity following systemic administration of N-methyl-D-aspartic acid in dentate granule cells of murine hippocampus. Neuroscience. 93:1999;19-31.